Tumor P38MAPK Signaling Enhances Breast Carcinoma Vascularization and Growth by Promoting Expression and Deposition of Pro-Tumorigenic Factors

Oncotarget - United States
doi 10.18632/oncotarget.18755
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

High-Concentration Glucose Enhances Invasion in Invasive Ductal Breast Carcinoma by Promoting Glut1/Mmp2/Mmp9 Axis Expression

Oncology Letters
Cancer ResearchOncology
2017English

Syndecan-1 Expression by Stromal Fibroblasts Promotes Breast Carcinoma Growth in Vivo and Stimulates Tumor Angiogenesis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

CTCF Genetic Alterations in Endometrial Carcinoma Are Pro-Tumorigenic

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

ATR Suppresses the Pro-Tumorigenic Functions of Breast Stromal Fibroblasts

Oncotarget
Oncology
2018English

WITHDRAWN: Curcumin Shifts RAS-induced Pro-Proliferative MEK/ERK-signaling Toward Pro-Apoptotic P38MAPK/JNK1-signaling, Triggering P53 Activation and Apoptosis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth

PLoS ONE
Multidisciplinary
2012English

GD3 Synthase Expression Enhances Proliferation and Tumor Growth of MDA-MB-231 Breast Cancer Cells Through C-Met Activation

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

FTY720 Inhibits Tumor Growth and Enhances the Tumor-Suppressive Effect of Topotecan in Neuroblastoma by Interfering With the Sphingolipid Signaling Pathway

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2013English

Expression of Growth Factors and Tyrosine Kinase Receptors in the Primary Tumor and Tumor Thrombus Cells in Patients With Renal Cell Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy